Analyst Report: MOS

1. EXECUTIVE SUMMARY

Mosaic rose 17.37% to $21.62 on Wednesday 4 November 2026, the session after it reported third-quarter results on the evening of 3 November. According to Investing.com, investors looked past an EPS miss and focused on cost cuts, the sulfur supply position and management's statement that the fourth quarter will be the EBITDA trough for phosphate and the company. Volume of 22,235,600 shares was 2.44x the 50-day average, and the stock had fallen 3.21% in the session before the print, so the rally reversed a weak run-up. The stock still sits 11.23% lower year to date and below its 200-day average, and analysts had been cutting targets into the low $20s. The next test is whether fourth-quarter results confirm the trough.

2. THE CATALYST

Mosaic reported Q3 2026 results after the close on 3 November, and the shares rose sharply after hours, according to Investing.com. Outlets put the after-hours gain at roughly 9.6% to 9.8%, and the regular session on 4 November finished well above that at +17.37%.

Motley Fool reported these third-quarter figures:

Investing.com reported that EPS missed consensus while revenue slightly beat. The brief carries conflicting consensus figures, a $0.01 profit in one report and a $0.03 loss in another, so the size of the miss is not established.

The points that drove the reaction came from the call. Per Investing.com, management said Q4 will be the EBITDA trough, and the CFO tied this to cash benefits from a $615/t sulfur contract and lower sulfur prices starting immediately. Yahoo Finance's call summary, which the brief could read only as a description, says the company expects positive free cash flow in the second half of 2026 despite phosphate curtailments.

3. COMPANY PROFILE

Mosaic is a Basic Materials company in agricultural inputs. It produces and sells concentrated phosphate and potash crop nutrients through three segments: Phosphates, Potash and Mosaic Fertilizantes. Products include diammonium phosphate, monoammonium phosphate and the value-added MicroEssentials. The market capitalisation is $6.87bn, the forward P/E is 14.2 and the dividend yield is 4.78%. Peers in the site's group include CF, which is the closest fertilizer competitor.

Recent results from the brief (Motley Fool, 4 November):

• Phosphate sales volumes were 1.4 million tonnes (1.6 a year earlier), potash 2.1 million (2.3) and Mosaic Fertilizantes 1.9 million (2.8).
• Phosphate production was curtailed to match affordable sulfur, and Louisiana capacity was idled. Phosphate cash conversion cost improved to $117/t from $131/t.
• 2026 capex was cut to $1.2 billion from $1.5 billion, and 2027 capex is targeted below $1 billion.
• Q4 guidance: realized sulfur $800–850/t, ammonia $590–610/t and a stripping margin in the mid-$300s/t.

Investing.com adds that Q3 realized sulfur was $715/t against a market average of $1,100, and that volumes at the $615/t Q4 contract price do not fully run U.S. assets. Debt maturities due in 2027 and 2028 were refinanced in early August, Canadian land sales netted $36 million, and the Araxá sale process is advancing.

4. DEEP DIVE ANALYSIS

Do fundamentals justify the move? Earnings fell sharply from a year earlier, so the print itself gave little support. The rally rests on direction: a named trough quarter, lower input costs, cheaper conversion, reduced capex and a refinanced balance sheet. Management also said North American fall phosphate demand was stronger than expected and that it sees green shoots, while calling a recovery too early. Customer credit remains constrained, and management expects better 2027 demand from farm economics and low inventories (Investing.com).

Positioning. In the weeks before the print, Mizuho cut its target to $22 from $25 (MarketBeat, 13 October) and Barclays cut to $22 from $26 (StocksToTrade, 23 October). The stock closed at $17.27 on 22 October, near the 52-week low of $16.99 set that day. Our inference is that low expectations and a weak pre-print tape amplified the response to any reassurance, which fits the 17.37% move.

Analyst reaction. Mizuho lowered its target again to $20 from $22 with a Neutral rating, citing margin pressure (Investing.com). That target sits below the $21.62 close. The latest consensus in the brief, dated 13 October, was 6 Buy, 13 Hold and 3 Sell with an average target near $26.89 (MarketBeat). KeyBanc is mentioned as initiating at Sector Weight with a $26 target, but the source gives no date. Freedom Broker items conflict (an upgrade to Hold and a separate downgrade to Sell with a $17 target, both undated or unverified), so they carry no weight here.

Peers. In the same period CF fell 4.39% while the S&P 500 rose 1.58%. The brief found no source explaining peer moves, so the read-across is limited. Investing.com mentions a potential U.S.-announced potash deal with Belarus that reportedly weighed on fertilizer producers, but the date is unclear and it comes from a single source. Management also cited Baltic shipping disruptions and a Persian Gulf disruption.

Comparable episode. At the Q2 report on 4 August, Mosaic posted a $273 million net loss and cut 2026 capex guidance to $1.2 billion (company 8-K). The brief has no price reaction for that date.

Bull case. The trough is behind the company, sulfur costs fall immediately, free cash flow turns positive in the second half, capex drops below $1 billion in 2027 and the dividend yield is 4.78%.

Bear case. Q4 is guided as the low point, and the stripping margin is only in the mid-$300s/t. U.S. assets are not fully run at the contract sulfur volumes, customer credit is tight, and no 2027 stripping-margin figure has been given. Sell-side targets remain near or below the current price.

5. TECHNICAL SNAPSHOT

The $21.62 close sits just below the 50-day average of $21.75 and well below the 200-day average of $23.46. It is 31.7% under the 52-week high of $31.66 from 12 March and 27.2% above the 52-week low of $16.99 from 22 October. Volume of 22,235,600 was 2.44x the 50-day average and well above any other session in the table, which indicates broad participation in the move. The session high of $21.65 sits barely above the close. The nearest support is the prior close of $19.03 from 2 November, and the 50-day average at $21.75 is the first overhead level. No close in the table exceeds the latest one.

6. RISK FACTORS

• The after-hours gain was about 9.8% and the session gained 17.37%, so a large part of the move came after the initial reaction and can retrace.
• Q4 results will test the trough claim, and the next earnings date is not in the brief.
• Sulfur supply is exposed to Baltic and Persian Gulf disruptions cited by management.
• Customer credit constraints and lower sales volumes across all three segments.
• A Belarus potash deal, reported by a single undated source, could add supply to the potash market.
• Sell-side targets remain cautious, with Mizuho at $20.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks): The stock sits at the 50-day average of $21.75. A close above it would open the way toward the 200-day average of $23.46, and a slip back would put the $19.03 level in view. Large one-day gains followed by 2.44x volume often see some consolidation; this is inference and not a forecast. Analyst target revisions after the call are the main near-term input.

Medium term (1-3 months): Evidence that phosphate production and cash conversion costs hold their improvement, sulfur pricing follows the Q4 guidance, and fall demand stays firm would support the stock. Delays to the trough or a weaker stripping margin than the mid-$300s/t would pressure it.

Long term: The thesis has shifted from deteriorating margins to a recovery that depends on 2027 demand and cost discipline. Management has not committed to a recovery, and the balance sheet work and capex cuts reduce financial strain without resolving earnings power. This is analysis only and not personal financial advice.